Genomics data management and analysis platform DNAStack has secured a follow-on investment from Facit, building on the commercialisation unit's initial commitment in 2017.
Canada-based genomics data management business DNAStack attracted an undisclosed sum yesterday from Fight Against Cancer Innovation Trust (Facit), a commercialisation operation backed by Ontario Institute for Cancer Research. The cash came through Facit’s Compass Rose Oncology Fund, an investment vehicle that mainly backs Ontario-based technologies with the potential to benefit patients with cancer. Founded in 2014, DNAStack…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
